PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
To obtain preliminary data in a randomized phase II study whether PPX/RT improves
progression-free survival as compared to temozolomide/RT for patients with GBM without MGMT
methylation.
Phase:
Phase 2
Details
Lead Sponsor:
Brown University
Collaborators:
Maine Medical Center MaineHealth Milton S. Hershey Medical Center Rhode Island Hospital Thomas Jefferson University University of California, San Diego University of Massachusetts, Worcester University of Washington